£74.00

About as cheap as it gets — within 5% of the all-time low it hit 1 month ago.

£74 today · all-time low £74 (Sep 2026) · usually the usual

Springer Lipoprotein Deficiency Syndromes: 201 (Advances in Experimental Medicine and Biology, 201)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 57 days · 57 data points (no recent data)

Historical
Generating forecast…
£75.88 £73.50 £74.02 £74.54 £75.06 £75.58 £76.10 23 July 2026 06 August 2026 20 August 2026 03 September 2026 17 September 2026
View at Amazon ↗

Price data last checked 34 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 57 days • 3 price levels

Days at Price
Current Price
11 days · current 32 days 14 days 0 8 16 24 32 £74 £75 £76 Days at Price

Price Analysis

Most common price: £75 (32 days, 56.1%)

Price range: £74 - £76

Price levels: 3 different prices over 57 days

Description

Current interest in lipoprotein deficiency states stems from the growing realization of their importance in the etiology of premature coronary heart disease. While hypercholesterolemia and coronary heart disease risk are strongly correlated in their etiologic relationship, it is becoming equally clear that deficiencies in HDL, whether congenital or acquired, also enhance the risk for the future development of coronary atherosclerosis. This has led to renewed attention to the lipid hypothesis and realization of the fact that each lipoprotein class and apoprotein species has specific functions in the transport and cellular uptake of various lipids. It is a truism that a biochemical correlate of disease once identified is subsequently recognized with increasing frequency in clinical medicine. The story of HDL was no exception. Indeed hypoalphalipoproteinemia appears to be a disease of high prevalence approaching and perhaps even exceeding that of familial hypercholesterolemia. Its clinical signifi cance escaped our notice for many years largely due to a heavy emphasis on hypercholesterolemia and to difficulties in measuring HDL reliably.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
23 October 2012
Listed Since
06 August 2014

Barcode

No barcode data available

Similar Products You Might Like

Disorders of Lipid Metabolism
81% match

Disorders of Lipid Metabolism

Springer

£73.85 21 Oct 2026
High-Density Lipoproteins as Biomarkers and Therapeutic Tools: Volume 1. Impacts of Lifestyle, Diseases, and Environmental Stressors on HDL
81% match

High-Density Lipoproteins as Biomarkers and Therapeutic Tools: Volume 1. Impacts of Lifestyle, Diseases, and Environmental Stressors on HDL

Springer

£107.88 07 Aug 2026
The Lipoprotein Molecule: 15 (NATO Science Series A:, 15)
81% match

The Lipoprotein Molecule: 15 (NATO Science Series A:, 15)

Springer

£75.42 12 Sep 2026
Cellular Lipid Binding Proteins: 38 (Developments in Molecular and Cellular Biochemistry, 38)
79% match

Cellular Lipid Binding Proteins: 38 (Developments in Molecular and Cellular Biochemistry, 38)

Springer

£119.86 07 Aug 2026
Oxidative Stress and Vascular Disease: 224 (Developments in Cardiovascular Medicine, 224)
79% match

Oxidative Stress and Vascular Disease: 224 (Developments in Cardiovascular Medicine, 224)

Springer

£146.26 07 Aug 2026
High-Density Lipoproteins as Biomarkers and Therapeutic Tools: Volume 2. Improvement and Enhancement of HDL and Clinical Applications
79% match

High-Density Lipoproteins as Biomarkers and Therapeutic Tools: Volume 2. Improvement and Enhancement of HDL and Clinical Applications

Springer

£92.22 08 Aug 2026
Biochemistry of Atherosclerosis: 1 (Advances in Biochemistry in Health and Disease, 1)
79% match

Biochemistry of Atherosclerosis: 1 (Advances in Biochemistry in Health and Disease, 1)

Springer

£54.80 13 Aug 2026
Bioactive Lipids in Health and Disease: 1127 (Advances in Experimental Medicine and Biology, 1127)
78% match

Bioactive Lipids in Health and Disease: 1127 (Advances in Experimental Medicine and Biology, 1127)

Springer

£112.84 17 Oct 2026
Lipids: Chemistry, Biochemistry, and Nutrition
78% match

Lipids: Chemistry, Biochemistry, and Nutrition

Springer

£77.49 11 Sep 2026
Oxidative Stress and Vascular Disease: 224 (Developments in Cardiovascular Medicine, 224)
78% match

Oxidative Stress and Vascular Disease: 224 (Developments in Cardiovascular Medicine, 224)

Springer

£179.99 08 Aug 2026
Lipid Signaling in Human Diseases: 259 (Handbook of Experimental Pharmacology, 259)
78% match

Lipid Signaling in Human Diseases: 259 (Handbook of Experimental Pharmacology, 259)

Springer

£108.01 14 Sep 2026
Lipid-mediated Protein Signaling: 991 (Advances in Experimental Medicine and Biology, 991)
77% match

Lipid-mediated Protein Signaling: 991 (Advances in Experimental Medicine and Biology, 991)

Springer

£108.01 07 Aug 2026
Lipid Signaling in Human Diseases: 259 (Handbook of Experimental Pharmacology, 259)
77% match

Lipid Signaling in Human Diseases: 259 (Handbook of Experimental Pharmacology, 259)

Springer

£108.01 07 Aug 2026
Sphingolipids and Metabolic Disease: 721 (Advances in Experimental Medicine and Biology, 721)
77% match

Sphingolipids and Metabolic Disease: 721 (Advances in Experimental Medicine and Biology, 721)

Springer

£114.75 08 Aug 2026
Tobacco Smoking and Atherosclerosis: Pathogenesis and Cellular Mechanisms: 273 (Advances in Experimental Medicine and Biology, 273)
77% match

Tobacco Smoking and Atherosclerosis: Pathogenesis and Cellular Mechanisms: 273 (Advances in Experimental Medicine and Biology, 273)

Springer

£76.38 05 Aug 2026
Arteriosclerosis: New Insights into Pathogenetic Mechanisms and Prevention
77% match

Arteriosclerosis: New Insights into Pathogenetic Mechanisms and Prevention

Springer

£77.54 13 Aug 2026
Sex Differences in Heart Disease: 21 (Advances in Biochemistry in Health and Disease)
76% match

Sex Differences in Heart Disease: 21 (Advances in Biochemistry in Health and Disease)

Springer

£115.47 06 Aug 2026
Peroxisomal Disorders and Regulation of Genes: 544 (Advances in Experimental Medicine and Biology, 544)
76% match

Peroxisomal Disorders and Regulation of Genes: 544 (Advances in Experimental Medicine and Biology, 544)

Springer

£109.08 07 Aug 2026
Lipidology, An Issue of Cardiology Clinics (Volume 33-2) (The Clinics: Internal Medicine, Volume 33-2)
76% match

Lipidology, An Issue of Cardiology Clinics (Volume 33-2) (The Clinics: Internal Medicine, Volume 33-2)

Elsevier

£55.51 09 Sep 2026
Sphingolipid Biology
76% match

Sphingolipid Biology

Springer

£139.86 14 Sep 2026
Vascular Disorders of the Liver: VALDIG's Guide to Management and Causes
76% match

Vascular Disorders of the Liver: VALDIG's Guide to Management and Causes

Springer

£96.65 17 Aug 2026
Lipidomics in Health & Disease: Methods & Application: 14 (Translational Bioinformatics, 14)
76% match

Lipidomics in Health & Disease: Methods & Application: 14 (Translational Bioinformatics, 14)

Springer

£76.42 08 Aug 2026
Lipid Metabolism in Mammals: 2 (Monographs in Lipid Research, 2)
75% match

Lipid Metabolism in Mammals: 2 (Monographs in Lipid Research, 2)

Springer

£76.42 06 Aug 2026
Hydrophilic Vitamins in Health and Disease (Advances in Biochemistry in Health and Disease, 29)
75% match

Hydrophilic Vitamins in Health and Disease (Advances in Biochemistry in Health and Disease, 29)

Springer

£113.98 14 Aug 2026